Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir and Ledipasvir to Prevent HCV Recurrence After Liver Transplant
NCT02478229Phase 3Terminated
- Sponsor
- University Health Network
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir, ledipasvir in Hepatitis C genotype 1, sponsored by University Health Network. Started Jun 2015; status: terminated.
02
Drugs
sofosbuvirledipasvir
03
Conditions
Hepatitis C genotype 1
Beyond the preview
Go deeper on NCT02478229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478229.